Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Norman

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Experimental Nephrology|May 6, 1998
Differential response of activated versus non-activated renal fibroblasts to tubular epithelial cells: a model of initiation and progression of fibrosis?M P Lewis, J T Norman
Kidney International|July 18, 2008
Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeuticsLeon G Fine, Jill T Norman
Urology|May 1, 1992
Patient satisfaction with pharmacologic erection programJ B Hollander, J Gonzalez, T Norman
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1992
Relationship of symptomatology of schizophrenia and tardive dyskinesiaA Perenyi, T Norman, G D Burrows
Journal of Affective Disorders|June 1, 1982
Ligand binding and platelet uptake studies of loxapine, amoxapine and their 8-hydroxylated derivativesA Fulton, T Norman, G D Burrows
Kidney360|December 26, 2024
A FRMDable Future for Fibrosis?Fiona E Karet Frankl, Jill T Norman
European Journal of Cell Biology|June 1, 1993
Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney diseaseP D Wilson, J Du, J T Norman
Kidney International|September 18, 1997
Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanismC Orphanides, L G Fine, J T Norman
Trials|April 19, 2024
A maturity model for the scientific review of clinical trial designs and their informativenessS Dolley, T Norman, D McNair, et al.
Journal of Affective Disorders|July 21, 1998
Negative symptoms, depression, and parkinsonian symptoms in chronic, hospitalised schizophrenic patientsA Perenyi, T Norman, M Hopwood, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Experimental Nephrology|May 6, 1998
Differential response of activated versus non-activated renal fibroblasts to tubular epithelial cells: a model of initiation and progression of fibrosis?M P Lewis, J T Norman
Kidney International|July 18, 2008
Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeuticsLeon G Fine, Jill T Norman
Urology|May 1, 1992
Patient satisfaction with pharmacologic erection programJ B Hollander, J Gonzalez, T Norman
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1992
Relationship of symptomatology of schizophrenia and tardive dyskinesiaA Perenyi, T Norman, G D Burrows
Journal of Affective Disorders|June 1, 1982
Ligand binding and platelet uptake studies of loxapine, amoxapine and their 8-hydroxylated derivativesA Fulton, T Norman, G D Burrows
Kidney360|December 26, 2024
A FRMDable Future for Fibrosis?Fiona E Karet Frankl, Jill T Norman
European Journal of Cell Biology|June 1, 1993
Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney diseaseP D Wilson, J Du, J T Norman
Kidney International|September 18, 1997
Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanismC Orphanides, L G Fine, J T Norman
Trials|April 19, 2024
A maturity model for the scientific review of clinical trial designs and their informativenessS Dolley, T Norman, D McNair, et al.
Journal of Affective Disorders|July 21, 1998
Negative symptoms, depression, and parkinsonian symptoms in chronic, hospitalised schizophrenic patientsA Perenyi, T Norman, M Hopwood, et al.
Pageof 14